Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lombardo, Angela"'
Autor:
Stephenson, Kathryn E., Keefer, Michael C., Bunce, Catherine A., Frances, Doreen, Abbink, Peter, Maxfield, Lori F., Neubauer, George H., Nkolola, Joseph, Peter, Lauren, Lane, Christopher, Park, Harriet, Verlinde, Carl, Lombardo, Angela, Yallop, Christopher, Havenga, Menzo, Fast, Patricia, Treanor, John, Barouch, Dan H.
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0205139 (2018)
PLoS ONE, Vol 13, Iss 11, p e0205139 (2018)
BACKGROUND:Live, attenuated viral vectors that express HIV-1 antigens are being investigated as an approach to generating durable immune responses against HIV-1 in humans. We recently developed a replication-competent, highly attenuated Ad26 vector t
Autor:
Vasan, Sandhya, Schlesinger, Sarah J., Zhiwei Chen, Hurley, Arlene, Lombardo, Angela, Than, Soe, Adesanya, Phumla, Bunce, Catherine, Boaz, Mark, Boyle, Rosanne, Sayeed, Eddy, Clark, Lorna, Dugin, Daniel, Boente-Carrera, Mar, Schmidt, Claudia, Qing Fang, Lei Ba, Yaoxing Huang, Zaharatos, Gerasimos J., Gardiner, David F.
Publikováno v:
PLoS ONE; 2010, Vol. 5 Issue 1, p1-7, 7p, 1 Diagram, 4 Charts, 2 Graphs
Autor:
Vasan, Sandhya, Schlesinger, Sarah J., Yaoxing Huang, Hurley, Arlene, Lombardo, Angela, Zhiwei Chen, Than, Soe, Adesanya, Phumla, Bunce, Catherine, Boaz, Mark, Boyle, Rosanne, Sayeed, Eddy, Clark, Lorna, Dugin, Daniel, Schmidt, Claudia, Yang Song, Seamons, Laura, Dally, Len, Ho, Martin, Smith, Carol
Publikováno v:
PLoS ONE; 2010, Vol. 5 Issue 1, p1-7, 7p, 1 Diagram, 3 Charts, 1 Graph
Autor:
Omosa-Manyonyi G; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Mpendo J; Uganda Virus Research Institute-IAVI, Entebbe, Uganda., Ruzagira E; Medical Research Council (MRC)/Uganda Virus Research Institute (UVRI), Uganda, Research Unit on AIDS, Entebbe, Uganda., Kilembe W; Zambia Emory HIV Research Program, Lusaka, Zambia., Chomba E; University Teaching Hospital, Lusaka, Zambia., Roman F; GlaxoSmithKline Vaccines, Rixensart, Belgium., Bourguignon P; GlaxoSmithKline Vaccines, Rixensart, Belgium., Koutsoukos M; GlaxoSmithKline Vaccines, Rixensart, Belgium., Collard A; GlaxoSmithKline Vaccines, Rixensart, Belgium., Voss G; GlaxoSmithKline Vaccines, Rixensart, Belgium., Laufer D; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Stevens G; IAVI, Johannesburg, South Africa., Hayes P; IAVI, Human Immunology Laboratory, London, United Kingdom., Clark L; IAVI, Human Immunology Laboratory, London, United Kingdom., Cormier E; IAVI, Human Immunology Laboratory, London, United Kingdom., Dally L; EMMES Corporation, Rockville, MD, United States of America., Barin B; EMMES Corporation, Rockville, MD, United States of America., Ackland J; Global BioSolutions, Melbourne, Australia., Syvertsen K; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Zachariah D; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Anas K; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Sayeed E; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Lombardo A; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Gilmour J; IAVI, Human Immunology Laboratory, London, United Kingdom., Cox J; IAVI, Human Immunology Laboratory, London, United Kingdom., Fast P; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Priddy F; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 May 11; Vol. 10 (5), pp. e0125954. Date of Electronic Publication: 2015 May 11 (Print Publication: 2015).